• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of Office of Science and Engineering Laboratories (OSEL) intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent
Oct 20128588
Nov 20128595
Dec 20128591
Jan 20138594
Feb 20138596
Mar 20138598
Apr 20138597
May 20138593
Jun 20138597
Jul 20138594
Aug 20138595
Sep 20138595

FY 2013 Overall: 94%

Number of OSEL intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A138
Nov 2012N/A146
Dec 2012N/A128
Jan 2013N/A160
Feb 2013N/A133
Mar 2013N/A157
Apr 2013N/A193
May 2013N/A161
Jun 2013N/A171
Jul 2013N/A192
Aug 2013N/A181
Sep 2013N/A167

FY 2013 Total: 1,939

Total number of OSEL intra- and inter-Office eConsults completed during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A157
Nov 2012N/A154
Dec 2012N/A140
Jan 2013N/A171
Feb 2013N/A138
Mar 2013N/A161
Apr 2013N/A199
May 2013N/A174
Jun 2013N/A176
Jul 2013N/A204
Aug 2013N/A191
Sep 2013N/A176

FY 2013 Total: 2,053

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.